T1	PROC 46 120	Estudio en fase II, aleatorizado, enmascarado, multicéntrico y comparativo
T2	PROC 258 265	tratado
#1	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	CHEM 127 136	veliparib
#2	AnnotatorNotes T3	C1958300; veliparib; Organic Chemical · Pharmacologic Substance
T4	PROC 141 148	FOLFIRI
#3	AnnotatorNotes T4	C1880658; Folinic Acid-Fluorouracil-Irinotecan Regimen; Therapeutic or Preventive Procedure
T5	CHEM 151 162	bevacizumab
#4	AnnotatorNotes T5	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	PROC 172 179	placebo
#5	AnnotatorNotes T6	C0032042; Placebos; Therapeutic or Preventive Procedure
T7	PROC 184 191	FOLFIRI
#6	AnnotatorNotes T7	C1880658; Folinic Acid-Fluorouracil-Irinotecan Regimen; Therapeutic or Preventive Procedure
T8	CHEM 194 205	bevacizumab
#7	AnnotatorNotes T8	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T9	DISO 212 242	cáncer colorrectal metastásico
#8	AnnotatorNotes T9	C4721579; Secondary malignant neoplasm of colon and/or rectum; Neoplastic Process
T10	PROC 335 342	tratado
#9	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	DISO 289 319	Cáncer colorrectal metastásico
#10	AnnotatorNotes T11	C4721579; Secondary malignant neoplasm of colon and/or rectum; Neoplastic Process
T12	DISO 390 439	Adenocarcinoma del colon o del recto, metastásico
#11	AnnotatorNotes T12	C4721579; Secondary malignant neoplasm of colon and/or rectum; Neoplastic Process
T13	ANAT 409 414	colon
#12	AnnotatorNotes T13	C0009368; Colon structure; Body Part, Organ, or Organ Component | C1281569; Entire colon; Body Part, Organ, or Organ Component
T14	ANAT 421 426	recto
#13	AnnotatorNotes T14	C0034896; Rectum; Body Part, Organ, or Organ Component | C1278926; Entire rectum; Body Part, Organ, or Organ Component
T15	DISO 500 506	lesión
#14	AnnotatorNotes T15	C0221198; Lesion; Finding
T16	ANAT 657 662	renal
#15	AnnotatorNotes T16	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T17	ANAT 665 673	hepática
#16	AnnotatorNotes T17	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T18	PROC 711 733	Tratamiento oncológico
#17	AnnotatorNotes T18	C0920425; cancer treatment; Therapeutic or Preventive Procedure
T19	DISO 745 775	cáncer colorrectal metastásico
#18	AnnotatorNotes T19	C4721579; Secondary malignant neoplasm of colon and/or rectum; Neoplastic Process
T20	CHEM 799 821	inhibidores de la PARP
#19	AnnotatorNotes T20	C1882413; Poly(ADP-ribose) Polymerase Inhibitors; Organic Chemical · Pharmacologic Substance
T21	PROC 847 870	quimioterapia adyuvante
#20	AnnotatorNotes T21	C0085533; Chemotherapy, Adjuvant; Therapeutic or Preventive Procedure
T22	DISO 929 947	cáncer colorrectal
#21	AnnotatorNotes T22	C0346629; Malignant neoplasm of large intestine; Neoplastic Process | C1319315; Adenocarcinoma of large intestine; Neoplastic Process | C4722085; Malignant neoplasm of colon and/or rectum; Neoplastic Process
T23	DISO 1202 1211	toxicidad
#22	AnnotatorNotes T23	C0600688; Toxic effect; Injury or Poisoning
T24	CHEM 1239 1250	bevacizumab
#23	AnnotatorNotes T24	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T25	ANAT 219 230	colorrectal
#24	AnnotatorNotes T25	C0391908; colon rectal; Body Part, Organ, or Organ Component | C0391908; Colon and rectum; Body Part, Organ, or Organ Component | C1711309; Colorectal Region; Body Location or Region
T26	ANAT 296 307	colorrectal
#25	AnnotatorNotes T26	C0391908; colon rectal; Body Part, Organ, or Organ Component | C0391908; Colon and rectum; Body Part, Organ, or Organ Component | C1711309; Colorectal Region; Body Location or Region
T27	PROC 526 528	TC
#26	AnnotatorNotes T27	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T28	ANAT 752 763	colorrectal
#27	AnnotatorNotes T28	C0391908; colon rectal; Body Part, Organ, or Organ Component | C0391908; Colon and rectum; Body Part, Organ, or Organ Component | C1711309; Colorectal Region; Body Location or Region
T29	ANAT 936 947	colorrectal
#28	AnnotatorNotes T29	C0391908; colon rectal; Body Part, Organ, or Organ Component | C0391908; Colon and rectum; Body Part, Organ, or Organ Component | C1711309; Colorectal Region; Body Location or Region
T30	DISO 961 978	condición clínica
T31	Date 13 17	2014
T32	Neg_cue 255 257	no
T33	Neg_cue 332 334	no
T34	Age 379 386	18 años
T36	Duration 893 903	> 12 meses
T37	LIVB 1022 1069	Pacientes embarazadas o en periodo de lactancia
#29	AnnotatorNotes T37	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T38	LIVB 1117 1129	investigador
#30	AnnotatorNotes T38	C0035173; Research Personnel; Professional or Occupational Group
T39	LIVB 1160 1168	paciente
#31	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T41	PHYS 1032 1043	embarazadas
#32	AnnotatorNotes T41	C0032961; Pregnancy; Organism Function
T35	PHYS 635 673	Función hematológica, renal y hepática
#33	AnnotatorNotes T35	C0221130; Hematologic function; Organ or Tissue Function + C0232804; Renal function; Organ or Tissue Function + C0232741; Liver function; Organ or Tissue Function
T40	Spec_cue 1175 1181	riesgo
T42	PHYS 1060 1069	lactancia
#34	AnnotatorNotes T42	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T43	PROC 601 617	Estado funcional
#35	AnnotatorNotes T43	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T44	DISO 916 924	recidiva
#36	AnnotatorNotes T44	C2825055; Recurrence (disease attribute); Pathologic Function
T45	PROC 452 481	histológica o citológicamente
#37	AnnotatorNotes T45	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T10 Negated
A2	Assertion T2 Negated
A3	Assertion T23 Speculated
A4	Status T2 History_of
A5	Status T10 History_of
A6	Status T18 History_of
A7	Status T20 History_of
A8	Status T21 History_of
A9	Status T24 History_of
#38	AnnotatorNotes T1	C0282460; Phase 2 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0150108; Blinded; Research Activity + C1096776; Multicenter Study; Research Activity + C1579762; comparative study research; Research Activity
T46	Quantifier_or_Qualifier 1009 1019	contralada
A10	Assertion T46 Negated
T47	Neg_cue 1005 1007	no
R1	Location_of Arg1:T26 Arg2:T11	
R2	Negation Arg1:T33 Arg2:T10	
R4	Location_of Arg1:T14 Arg2:T12	
R5	Location_of Arg1:T13 Arg2:T12	
T48	Quantifier_or_Qualifier 485 499	Como mínimo, 1
R6	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T48	
T49	Observation 507 518	irresecable
#39	AnnotatorNotes T49	C4039777; Tumor surgically unresectable; Finding
R7	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T49	
T50	CONC 578 597	RECIST, versión 1.1
#40	AnnotatorNotes T50	C1709926; Response Evaluation Criteria in Solid Tumors; Intellectual Product
T51	Quantifier_or_Qualifier 537 547	mensurable
#41	AnnotatorNotes T51	C1513040; Measurable; Functional Concept
R9	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T51	
T52	CONC 618 622	ECOG
#42	AnnotatorNotes T52	C1520224; ECOG performance status; Intellectual Product
T53	Result_or_Value 626 631	0 o 1
R10	Has_Result_or_Value Arg1:T52 Arg2:T53	
R11	Used_for Arg1:T52 Arg2:T43	
R12	Location_of Arg1:T17 Arg2:T35	
R13	Location_of Arg1:T16 Arg2:T35	
T54	Quantifier_or_Qualifier 674 682	adecuada
#43	AnnotatorNotes T54	C0205411; Adequate; Qualitative Concept
R14	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T54	
R15	Location_of Arg1:T28 Arg2:T19	
T55	Quantifier_or_Qualifier 882 892	finalizado
#44	AnnotatorNotes T55	C1272693; Ended - status; Qualitative Concept
R16	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T55	
R17	Overlap Arg1:T55 Arg2:T36	
R18	Before Arg1:T21 Arg2:T44	
R19	Before Arg1:T22 Arg2:T44	
R20	Location_of Arg1:T29 Arg2:T22	
T56	Quantifier_or_Qualifier 979 992	significativa
#45	AnnotatorNotes T56	C1546944; Event Seriousness - Significant; Qualitative Concept
R21	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T56	
R22	Negation Arg1:T47 Arg2:T46	
R23	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T46	
R24	Experiences Arg1:T37 Arg2:T41	
R25	Experiences Arg1:T37 Arg2:T42	
R26	Speculation Arg1:T40 Arg2:T23	
R27	Experiences Arg1:T39 Arg2:T23	
T57	Observation 1175 1186	riesgo alto
#46	AnnotatorNotes T57	C4319571; High risk; Finding
R28	Experiences Arg1:T39 Arg2:T57	
R29	Before Arg1:T57 Arg2:T23	
R30	Combined_with Arg1:T3 Arg2:T4	
R31	Combined_with Arg1:T4 Arg2:T5	
R32	Combined_with Arg1:T6 Arg2:T7	
R33	Combined_with Arg1:T7 Arg2:T8	
R34	Location_of Arg1:T25 Arg2:T9	
R35	Negation Arg1:T32 Arg2:T2	
#47	AnnotatorNotes T30	C4745084; Medical Condition; Finding
A11	Experiencer T37 Patient
A12	Experiencer T38 Other
A13	Experiencer T39 Patient
